United States Multi-Omics Market 2024-2033: Transforming Precision Medicine & Drug Discovery | Top Companies are Thermo Fisher Scientific Inc., Illumina, Inc., Danaher Corporation

The Global Multi omics Market reached US$ 3.25 Billion in 2024 and is expected to reach US$ 33.25 Billion by 2033, growing at a CAGR of 26.1% during the forecast period 2025-2033.

The Multi-Omics Market focuses on integrative analysis of genomics, proteomics, metabolomics, and other omics data to understand disease mechanisms and identify biomarkers. Market growth is driven by precision medicine, drug discovery, and personalized healthcare. Advances in high-throughput sequencing, bioinformatics, and AI-enabled analytics enhance insight generation. Pharmaceutical companies, research institutions, and clinical labs are key end-users. Multi-omics approaches enable early diagnosis, treatment optimization, and biomarker discovery. Increasing investment in biotechnology and big data analytics supports continued market expansion.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Multi omics Market Landscape:- https://datamintelligence.com/download-sample/multiomics-market?Ranjith

☛ Multi omics Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In August 2025, Illumina launched a new multi-omics platform integrating genomics, transcriptomics, and proteomics for precision oncology. The system enables comprehensive tumor profiling to guide personalized therapies.

✅ In July 2025, Thermo Fisher Scientific expanded its multi-omics services with AI-driven data analytics. The platform accelerates biomarker discovery and supports drug development pipelines in biotech and pharmaceutical companies.

✅ In June 2025, BC Platforms partnered with major U.S. hospitals to implement multi-omics patient data solutions. The initiative integrates genomic, metabolomic, and clinical data to improve disease diagnosis and patient stratification.

Japan: Recent Industry Developments

✅ In August 2025, RIKEN Center for Integrative Medical Sciences launched a multi-omics initiative combining genomics, transcriptomics, and metabolomics for precision medicine research in cancer and metabolic disorders.

✅ In July 2025, Fujifilm Corporation introduced a high-throughput multi-omics platform for drug discovery. The system integrates protein, RNA, and DNA analyses, accelerating biomarker identification and therapeutic development.

✅ In June 2025, Takeda Pharmaceutical began applying multi-omics analytics in clinical trials for rare genetic disorders. The approach helps identify patient subgroups and optimize targeted therapy strategies.

Europe: Recent Industry Developments

✅ In August 2025, QIAGEN unveiled a multi-omics workflow combining DNA, RNA, and protein analysis for clinical research. The system is aimed at enabling faster biomarker discovery in cancer and rare diseases.

✅ In July 2025, Sartorius AG introduced an automated multi-omics sample preparation platform for high-throughput research. It reduces manual errors and improves reproducibility across genomics and proteomics studies.

✅ In June 2025, Evotec SE initiated a collaborative multi-omics project with European hospitals to analyze metabolic and proteomic profiles in neurodegenerative diseases. The program supports precision medicine approaches.

☛ Multi omics Market Competitive Landscape:

BD (Becton, Dickinson, and Company), Thermo Fisher Scientific Inc., Illumina, Inc., Danaher Corporation, Bruker Corporation, QIAGEN N.V, Agilent Technologies, Inc., Genedata, Shimadzu Corporation, and Element Biosciences.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/multiomics-market?Ranjith

☛ Segments Covered in the Multi omics Market:

Product & Service: Instruments | Consumables & Reagents | Services

Technology: Genomics | Transcriptomics | Proteomics | Metabolomics | Epigenomics

Application: Drug Discovery & Development | Precision Medicine | Clinical Diagnostics | Biotechnology & Industrial Applications

End-User: Pharmaceutical & Biotechnology Companies | Research Institutes & Academic Centers | Hospitals & Clinics | CROs & CDMOs

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Multi omics Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=multiomics-market?Ranjith

☛ Regional Analysis for Multi omics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.